Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Comparative Assessment of Four Virus Neutralization Assays for Detection of Sars-Cov-2 Neutralizing Antibodies Publisher Pubmed



Maghsood F1 ; Dashti N1 ; Bahadori T1 ; Golsazshirazi F1 ; Moog C2 ; Amiri MM1 ; Shokri F1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Laboratoire D'ImmunoRhumatologie Moleculaire, Institut National de la sante et de la recherche medicale (INSERM) UMR_S 1109, Institut thematique interdisciplinaire (ITI) de Medecine de Precision de Strasbourg, Transplantex NG, Faculte de Medecine, Federation Hospitalo-Universitaire OMICARE, Federation de Medecine Translationnelle de Strasbourg (FMTS), Iran

Source: Analytical Biochemistry Published:2025


Abstract

Neutralizing antibodies (NAbs) targeting receptor-binding domain (RBD) or spike of SARS-CoV-2 play an important role in blocking virus entry to the host cells and detecting their levels is critical for the assessment of humoral protective immune response following vaccination or recovery from SARS-CoV-2 infection. Here, we compared the performance of four virus neutralization tests to measure neutralizing antibodies in various sample types. We analyzed 25 serum samples obtained from mice or rabbits immunized with different vaccine platforms, and also 11 mouse anti-RBD monoclonal antibodies (MAbs) using surrogate virus neutralization test (SVNT), pseudovirus neutralization test (PVNT), conventional virus neutralization test (CVNT), and one-step or two-step inhibition flowcytometry virus neutralization test (IFVNT). All four VNTs showed significant correlations with each other, though PVNT and CVNT displayed significantly lower limit of detection (LoD) compared to the other two assays. In conclusion, our findings indicate that all four VNT assays give valid and accurate results and could be employed to determine the level of SARS-CoV-2 neutralizing monoclonal and polyclonal antibodies. © 2025